Race for coronavirus vaccine raises eyebrows at efficacy surrounding trials

04:59

Hanneke Schuitemaker, Johnson & Johnson Global Head of Viral Vaccine Development, and Dr. Dara Kass, Columbia Univ. Medical Center Associate Professor, join MSNBC's Craig Melvin to discuss the efficacy surrounding various trials and where we are on the time line for an approved vaccine.